NovaBridge Biosciences Incremental Common Shares Attributable to Dilutive Effect of Conversion of Preferred Stock
NovaBridge Biosciences (NBP) reported Incremental Common Shares Attributable to Dilutive Effect of Conversion of Preferred Stock of 4.37 million shares for the 12-month period ending 2020-12-31, per its 20-F filed 2023-05-01.
Discontinued › Income Statement › Earnings Per Share
us-gaap:IncrementalCommonSharesAttributableToConversionOfPreferredStock · last filed 2023-05-01
| Period end | Incremental Common Shares Attributable to Dilutive Effect of Conversion of Preferred Stock 12 month |
|---|---|
| 2020-12-31 | 4.37M shares 20-F · filed 2023-05-01 |